Advised Investcorp on its partial exit from NephroPlus as part of Quadria Capital’s INR 8.5 billion investment in NephroPlus.
Simone Reis
Shwetank Chaubey
Sarthak Parnami
Rishabh Chhabaria
Founded in 2010, NephroPlus is a company operating around 450 dialysis centres across Asia. Investcorp, a leading private equity firm, one of its early backers partially sold its stake in NephroPlus to Quadria Capital.
Quadria Capital is one of Asia’s largest healthcare-focused private equity firms with investments in single-specialty healthcare companies, such as eyecare chain Maxivision, and leading oncology network HCG.
Anagram Partners acted as the legal advisors to Investcorp. The team was led by our Partner, Simone Reis and comprised Shwetank Chaubey, Sarthak Parnami and Rishabh Chhabaria.
Read more at:
Quadria Capital picks up minority stake in NephroPlus for Rs 850 crore | Company Results – Business Standard (business-standard.com)
PE firm Quadria Capital investing ₹850 cr. for minority stake in NephroPlus – The Hindu
